TG Therapeutics Q1 2025 Earnings Preview

  • TG Therapeutics (NASDAQ:TGTX) is scheduled to announce Q1 earnings results on Monday, May 5th, before market open.
  • The consensus EPS Estimate is $0.17 (+342.9% Y/Y) and the consensus Revenue Estimate is $117.86M (+85.7% Y/Y).
  • Over the last 3 months, EPS estimates

Leave a Reply

Your email address will not be published. Required fields are marked *